Target intelligence / Profile preview

Cryptophane-A (CryA)

Target
CryA
Molecular classification
Supramolecular host, Cryptophane, Synthetic cage molecule
01

Overview

Cryptophane-A is a synthetic supramolecular host molecule composed of two cyclotriveratrylene (CTV) units connected by three ethylenedioxy linkers, creating a hydrophobic cavity (Brotin & Collet, 2007). It is primarily known for its exceptional affinity for xenon atoms, making it a cornerstone in the development of hyperpolarized 129Xe NMR biosensors (Spence et al., 2001). In these applications, Cryptophane-A acts as a host that encapsulates xenon, providing a unique chemical environment that results in a distinct NMR signal (Hill et al., 2007). By functionalizing the exterior of the cryptophane cage with targeting moieties such as antibodies or peptides, researchers can create biosensors that detect specific biological markers or cell types with high sensitivity (Witte et al., 2015). While not a therapeutic target itself, Cryptophane-A is a critical tool in molecular imaging and diagnostic research, particularly for the early detection of diseases like cancer (Rose et al., 2014). Therapeutic challenges associated with its use include its inherent lipophilicity and the requirement for chemical modification to ensure sufficient water solubility and biocompatibility for in vivo applications (Berthault et al., 2009).

Other names
Cryptophane-ACryAXenon-129 NMR biosensor host1,6,11-tris(2-methoxyethoxy)-2,7,12-trimethoxy-cryptophane-A
02

Mechanism of action

Host-guest encapsulation of Xenon-129 for hyperpolarized NMR signal detection.

03

Biological functions

Molecular sensingXenon-129 NMR biosensingContrast agent development
04

Disease associations

Cancer (diagnostic imaging)Molecular diagnostics
05

Safety considerations

Low aqueous solubilityBiocompatibility of synthetic scaffoldsPotential for non-specific binding
06

Biomarkers

Hyperpolarized 129Xe chemical shift

Beyond the preview

Go deeper on Cryptophane-A (CryA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryptophane-A (CryA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call